Pay in 4 interest-free payments of $6.93 Learn more
Ships within 48 hours Β· Estimated delivery Aug 29 - Sep 3
Results May Vary: Individual responses to GLP-1 medications vary significantly
Too much signal and the doseresponse curve flattens - you spend more money and expose yourself to more side effects for no extra benefit
Over 75% of health plans and over 50% of employers are moderately or very concerned about off-label use of GLP-1s approved for type 2 diabetes, but awareness of how much current spend is off-label is notably lower: nearly half of employers and a quarter of health plans are unsure
[Abstract]2022 Jul 4;12(1):11259
US$ 29.20
US$ 28.10
US$ 22.84
US$ 22.97
US$ 21.76
